- Home
- GROV vs NTRB Comparison
GROV vs NTRB Comparison
Compare GROV & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- NTRB
- Stock Information
- Founded
- GROV 2016
- NTRB 2016
- Country
- GROV United States
- NTRB United States
- Employees
- GROV N/A
- NTRB N/A
- Industry
- GROV Package Goods/Cosmetics
- NTRB Industrial Specialties
- Sector
- GROV Consumer Discretionary
- NTRB Health Care
- Exchange
- GROV Nasdaq
- NTRB Nasdaq
- Market Cap
- GROV 51.9M
- NTRB 49.2M
- IPO Year
- GROV N/A
- NTRB N/A
- Fundamental
- Price
- GROV $1.31
- NTRB $5.89
- Analyst Decision
- GROV Buy
- NTRB
- Analyst Count
- GROV 1
- NTRB 0
- Target Price
- GROV $2.00
- NTRB N/A
- AVG Volume (30 Days)
- GROV 167.4K
- NTRB 48.7K
- Earning Date
- GROV 11-07-2024
- NTRB 09-03-2024
- Dividend Yield
- GROV N/A
- NTRB N/A
- EPS Growth
- GROV N/A
- NTRB N/A
- EPS
- GROV N/A
- NTRB N/A
- Revenue
- GROV $227,251,000.00
- NTRB $1,803,816.00
- Revenue This Year
- GROV N/A
- NTRB N/A
- Revenue Next Year
- GROV $5.97
- NTRB N/A
- P/E Ratio
- GROV N/A
- NTRB N/A
- Revenue Growth
- GROV N/A
- NTRB N/A
- 52 Week Low
- GROV $1.19
- NTRB $1.53
- 52 Week High
- GROV $2.49
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- GROV 45.29
- NTRB 53.93
- Support Level
- GROV $1.24
- NTRB $5.70
- Resistance Level
- GROV $1.39
- NTRB $7.74
- Average True Range (ATR)
- GROV 0.09
- NTRB 0.67
- MACD
- GROV -0.01
- NTRB 0.03
- Stochastic Oscillator
- GROV 25.00
- NTRB 38.53
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.